Alzheimer’s disease susceptibility gene apolipoprotein e ( APOE ) and blood biomarkers in UK Biobank (N=395,769)
Preprint
Abstract
Background and objective: Alzheimer’s disease (AD) is a neurodegenerative condition where the underlying aetiology is still unclear. Investigating the potential influence of apolipoprotein e ( APOE ), a major genetic risk factor, on common blood biomarkers could provide a greater understanding of the mechanisms of AD and dementia risk. Our objective was to conduct the largest (to date) single-protocol investigation of blood biomarkers in the context of APOE genotype, in UK Biobank. Methods: After quality control and exclusions, data on 395,769 participants of White European ancestry were available for analysis. Linear regressions were used to test potential associations between APOE genotypes and biomarkers. Results: Several biomarkers significantly associated with APOE e4 ‘risk’ and e2 ‘protective’ genotypes (vs. neutral e3/e3). Most associations supported previous data: for example, e4 genotype was associated with elevated low-density lipoprotein cholesterol (LDL) (standardized beta [b] = 0.150 standard deviations [SDs] per allele, p<0.001) and e2 with lower LDL (b = −0.456 SDs, p<0.001). There were however instances of associations found in unexpected directions: e.g. e4 and increased insulin-like growth factor (IGF-1) (standardized beta = 0.017, p<0.001) where lower levels have been previously suggested as an AD risk factor. Conclusions: These findings highlight biomarker differences in non-demented people at genetic risk for dementia. The evidence here in supports previous hypotheses of involvement from cardiometabolic and neuroinflammatory pathways.Keywords
All Related Versions
- Published version: Journal of Alzheimer’s Disease, 76 (4), 1541.
This publication has 50 references indexed in Scilit:
- Plasma Biomarkers Associated With the Apolipoprotein E Genotype and Alzheimer DiseaseArchives of Neurology, 2012
- The Insulin-Like Growth Factor System in CancerEndocrinology and Metabolism Clinics of North America, 2012
- Apolipoprotein E and Apolipoprotein E Receptors: Normal Biology and Roles in Alzheimer DiseaseCold Spring Harbor Perspectives in Medicine, 2012
- Cystatin C in Alzheimer's diseaseFrontiers in Molecular Neuroscience, 2012
- The effects of apolipoprotein E on non-impaired cognitive functioning: A meta-analysisNeurobiology of Aging, 2011
- Association of Higher Levels of High-Density Lipoprotein Cholesterol in Elderly Individuals and Lower Risk of Late-Onset Alzheimer DiseaseArchives of Neurology, 2010
- Worldwide allele frequencies of the human apolipoprotein E gene: Climate, local adaptations, and evolutionary historyAmerican Journal of Physical Anthropology, 2010
- Serum cystatin C and the risk of Alzheimer disease in elderly menNeurology, 2008
- Serum elevated gamma glutamyltransferase levels may be a marker for oxidative stress in Alzheimer's diseaseInternational Psychogeriatrics, 2008
- Serum cholesterol and risk of Alzheimer diseaseNeurology, 2005